Quality of life for women treated with a more
targeted radiotherapy treatment - called accelerated partial breast irradiation - is at least as good as quality of life for women treated with standard radiotherapy, according...
Not exact matches
Breast cancer patients who have
radiotherapy targeted at the original tumour site experience fewer side effects five years after
treatment than those who have whole breast
radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet.
«
Targeted radiotherapy limits side effects of breast cancer
treatment.»
Work by University of Manchester scientists has explored what allows some cases of Ductal Carcinoma in Situ (DCIS), a non-invasive form of breast cancer, to resist
treatment and come back, as well as identifying a potential new
target to improve the effectiveness of
radiotherapy.
Although various
treatment options such as surgery,
radiotherapy, and chemotherapy are available, the mortality rate remains extremely high, so efforts are increasingly being
targeted at improving its detection and
treatment.
A number of
radiotherapies that marry a small but potent amount of radioactive material and a
targeted molecular compound have been gaining traction as progressive
treatments for malignant NETs, which can develop wherever nerve cells and hormone - producing endocrine cells are present (e.g., gastrointestinal tract, pancreas, lungs, thyroid).
Using ultrasound, Harris hopes to guide
radiotherapy treatment to
target the tumour more precisely.
Conventional medicine's main types of
treatment for breast cancer include surgery, radiation therapy, external beam
radiotherapy, chemotherapy,
targeted therapy, and hormone therapy.